SARM-3D Ingredients & Drug Interactions
What is this page for?
First and foremost: checking SARM-3D against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
SARM-3D is a dietary supplement by Hardcore Formulations with 3 active ingredients. Its ingredients are commonly taken for muscle building, athletic performance, fat loss / body recomposition.Based on those ingredients, 611 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Ostarine, Ligandrol. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against SARM-3D by Hardcore Formulations
Ask about any prescription or over-the-counter medication and we check it for interactions with SARM-3D by Hardcore Formulations — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of SARM-3D by Hardcore Formulations
Four independent checks of what is known — a summary of the available information, not a grade of the product itself.
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
The stated purpose hasn't been mapped to our evidence data yet.
Why this rating?
- We haven't mapped this product's purpose to our evidence data yet — it'll be graded on the next content refresh.
Every active ingredient lists its own amount on the label.
Why this rating?
- The label discloses an exact amount for 3 of its 3 active ingredients.
- “Selective Androgen Receptor Modulator Blend” is a proprietary blend — the label doesn't break down how much of each component you get.
The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.
Why this rating?
- 2 of the 2 matched ingredients can interact with medications — Ostarine, Ligandrol.
- The most serious interaction on file is rated Moderate.
- For scale: 612 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.
Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.
Why this rating?
- We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
- Pregnancy & breastfeeding safety ratings cover 2 of 2.
- General safety write-ups exist for 2 of 2.
- Remember: this measures how much safety information exists. Thin data is not the same as being safe.
HelloPharmacist summaryFully disclosed formula with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
Assessment coverage: 2 of 3 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Oct 25, 2018.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about SARM-3D, straight from the product label.
| Brand | Hardcore Formulations |
|---|---|
| Net contents | 60 Capsule(s) |
| Market status | Off market |
| Date entered into DSLD | Oct 25, 2018 |
| DSLD ID | 182743 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Capsule |
| Dietary claims / uses | Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for SARM-3D by Hardcore Formulations, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Ostarine | 25 mg | -- |
| Ligandrol | 10 mg | -- |
| Selective Androgen Receptor Modulator Blend | 0 NP | -- |
| Ibutamoren | 25 mg | -- |
Other ingredients: Gelatin, Silica, Magnesium Stearate
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements
Triple response SARM stack Warfare series
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Directions: For enhanced muscle gains and fat loss take 2 capsules before bedtime. Take in 8 week cycles with 2 week break between cycles.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
SARM-3D by Hardcore Formulations label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in SARM-3D by Hardcore Formulations
These are the 3 active ingredients this product is made of. Select any to open its full monograph.
Serving size2 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Other (inactive) ingredients: Gelatin, Silica, Magnesium Stearate. These complete the product’s ingredient list but are not active constituents.
SARM-3D by Hardcore Formulations Drug Interactions
SARM-3D contains 3 ingredients, and 2 of them have known drug interactions. Altogether they interact with 611 medications. Here’s the picture, then you can look up your own drug.
Want to check YOUR meds against SARM-3D?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in SARM-3D interact with 611 drugs. Click any drug to see the details.
2 of the 3 ingredients in SARM-3D interact with drugs. Each result below shows which ingredient is responsible. Ostarine Ligandrol
RezafunginRezzayo
How Rezafungin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Rezafungin interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rezafungin interactionRibociclib SuccinateKisqali
How Ribociclib Succinate interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Ribociclib Succinate interactionOstarineHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Ribociclib Succinate interactionRifabutinMycobutin
How Rifabutin interacts with SARM-3D — through 1 ingredient. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Rifabutin interactionRifampinRifadin, Rifadin Injection, Rimactane, Rofactor
How Rifampin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers, Rifampin (rifadin) +1 Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Rifampin interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rifampin interactionRifapentinePriftin
How Rifapentine interacts with SARM-3D — through 1 ingredient. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Rifapentine interactionRilpivirineEdurant, Edurant Ped
How Rilpivirine interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rilpivirine interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Rilpivirine interactionRiluzoleExservan, Rilutek, Tiglutik
How Riluzole interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Riluzole interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Riluzole interactionRipretinibQinlock
How Ripretinib interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Ripretinib interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Ripretinib interactionRitonavirNorvir
How Ritonavir interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full Ostarine + Ritonavir interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Ritonavir interactionRopeginterferon Alfa-2b-njftBesremi
How Ropeginterferon Alfa-2b-njft interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Ropeginterferon Alfa-2b-njft interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Ropeginterferon Alfa-2b-njft interactionRosiglitazone MaleateAvandia
How Rosiglitazone Maleate interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Rosiglitazone Maleate interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rosiglitazone Maleate interactionRosuvastatinCrestor, Ezallor
How Rosuvastatin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Rosuvastatin interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rosuvastatin interactionRosuvastatin Calcium, EzetimibeRoszet
How Rosuvastatin Calcium, Ezetimibe interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Rosuvastatin Calcium, Ezetimibe interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Rosuvastatin Calcium, Ezetimibe interactionRufinamideBanzel
How Rufinamide interacts with SARM-3D — through 1 ingredient. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Rufinamide interactionSarilumabKevzara
How Sarilumab interacts with SARM-3D — through 1 ingredient. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Sarilumab interactionSegesterone Acetate, Ethinyl EstradiolAnnovera
How Segesterone Acetate, Ethinyl Estradiol interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Segesterone Acetate, Ethinyl Estradiol interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Segesterone Acetate, Ethinyl Estradiol interactionSelpercatinibRetevmo
How Selpercatinib interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full Ostarine + Selpercatinib interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Selpercatinib interactionSimvastatinZocor
How Simvastatin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Simvastatin interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Simvastatin interactionSimvastatin, SitagliptinJuvisync
How Simvastatin, Sitagliptin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Simvastatin, Sitagliptin interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Simvastatin, Sitagliptin interactionSitaxsentan SodiumThelin
How Sitaxsentan Sodium interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sitaxsentan Sodium interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sitaxsentan Sodium interactionSodium ValproateEpilim
How Sodium Valproate interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sodium Valproate interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sodium Valproate interactionSomatrogon-ghlaNgenla
How Somatrogon-ghla interacts with SARM-3D — through 1 ingredient. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Somatrogon-ghla interactionSotorasibLumakras
How Sotorasib interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineCytochrome P450 3a4 (cyp3a4) Inducers, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full Ostarine + Sotorasib interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sotorasib interactionSparfloxacinZagam
How Sparfloxacin interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sparfloxacin interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sparfloxacin interactionSparsentanFilspari
How Sparsentan interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sparsentan interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sparsentan interactionStanozololWinstrol, Winstrol-V Chewable
How Stanozolol interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Stanozolol interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Stanozolol interactionSulfadiazineSulfadiazine
How Sulfadiazine interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sulfadiazine interactionOstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sulfadiazine interactionSulfadiazine, Sulfamerazine, SulfamethazineTerfonyl, Triple Sulfoid
How Sulfadiazine, Sulfamerazine, Sulfamethazine interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sulfadiazine, Sulfamerazine, Sulfamethazine interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sulfadiazine, Sulfamerazine, Sulfamethazine interactionSulfamethoxazoleGantanol
How Sulfamethoxazole interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
LigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sulfamethoxazole interactionOstarineHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full Ostarine + Sulfamethoxazole interactionSulfamethoxazole, TrimethoprimBactrim, Bactrim DS, Bactrim IV, Cotrim, Cotrim DS, Cotrimix +9 more
How Sulfamethoxazole, Trimethoprim interacts with SARM-3D — through 2 ingredients. Tap an ingredient for the detail:
OstarineCytochrome P450 2c9 (cyp2c9) Substrates, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full Ostarine + Sulfamethoxazole, Trimethoprim interactionLigandrolHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full Ligandrol + Sulfamethoxazole, Trimethoprim interactionEach ingredient & the kinds of drugs it affects
For each ingredient in SARM-3D with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
Ostarine
Cytochrome P450 3A4 (Cyp3A4) Inducers
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Ostarine is partially metabolized by CYP3A4. Clinical research shows that taking rifampin, a potent inducer of CYP3A4, reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%.
Hepatotoxic Drugs
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Some clinical research shows that ostarine can increase alanine aminotransferase, a marker of liver damage, in some patients. Additionally, the U.S. Food and Drug Administration warns that supplements containing SARMs, such as ostarine, have been associated with reports of liver toxicity and there are at least two reports of drug-induced liver injury attributed to the use of ostarine.
Probenecid (Benemid)
Theoretically, concomitant use of ostarine with probenecid could increase the effects and adverse effects of ostarine.
Clinical research shows that probenecid increases ostarine levels and slows the clearance of ostarine, likely via inhibition of UDP-glucuronosyltransferase (UGT). Ostarine is partially metabolized by UGT.
Rifampin (Rifadin)
Theoretically, concomitant use of ostarine with rifampin could decrease the clinical effects of ostarine.
Clinical research shows that taking rifampin with ostarine reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%. Ostarine is partially metabolized by cytochrome P450 3A4 (CYP3A4), and rifampin is a potent CYP3A4 inducer.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Although in vitro research suggests that ostarine inhibits CYP2C9, more robust clinical research shows that ostarine does not significantly affect CYP2C9.
Cytochrome P450 3A4 (Cyp3A4) Inhibitors
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Ostarine is partially metabolized by CYP3A4. However, clinical research shows that taking itraconazole, a potent inhibitor of CYP3A4, had minimal effects on the levels of ostarine in the body.
Ligandrol
Hepatotoxic Drugs
Theoretically, concomitant use might have additive hepatotoxic effects.
In case reports, patients were diagnosed with liver injury thought to be related to the use of products containing ligandrol.
Brand information
Manufacturer and brand details for SARM-3D, from the product label.
SARM-3D by Hardcore Formulations: Common Questions
Does SARM-3D by Hardcore Formulations interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if SARM-3D is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind SARM-3D’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Ostarine
Interacts with 611 drugsOstarine (also called MK-2866 or enobosarm) is an experimental, unapproved drug known as a SARM (selective androgen receptor modulator), not a true dietary supplement. It is not approved by...
Read the full Ostarine monograph → Herb & supplement monographLigandrol
Interacts with 370 drugsLigandrol (LGD-4033) is a synthetic selective androgen receptor modulator (SARM), not a natural herb or approved dietary supplement. It is not approved for human use, is banned in sports, an...
Read the full Ligandrol monograph →Sources & How We Checked
SARM-3D's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 19 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Ostarine 10 references
- Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
- Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
- Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
- Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 2013;14(4):335-45. PubMed
- Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II tri
- Coss CC, Jones A, Dalton JT. Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024 (enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. Invest New Drugs 2016;34(4):458-67. PubMed
- FDA. FDA Warns against using SARMs in body building products. October 2017. Available at: https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm.
- Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM. Drug-induced liver injury from enobosarm (ostarine), a selective androgen receptor modulator. ACG Case Rep J 2021;8(1):e00518. PubMed
- Kintz P, Gheddar L, Paradis C, et al. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- d) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516
- Weinblatt D, Roy S. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator. J Med Cases 2022;13(5):244-248. PubMed
Ligandrol 9 references
- Joseph JF, Parr MK. Synthetic androgens as designer supplements. Curr Neuropharmacol. 2015;13(1):89-100. PubMed
- Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
- Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
- Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
- Barbara M, Dhingra S, Mindikoglu AL. Drug-induced liver injury associated with alpha bolic (RAD-140) and alpha elite (RAD-140 and LGD-4033). ACG Case Rep J 2020;7(6):e00409. PubMed
- Barbara M, Dhingra S, Mindikoglu AL. Ligandrol (LGD-4033)-Induced Liver Injury. ACG Case Rep J 2020;7(6):e00370. PubMed
- Koller T, Vrbova P, Meciarova I, et al. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review. World J Clin Cases 2021;9(16):4062-4071. PubMed
- Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020;4(3):450-452. PubMed
- Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci 2013;68(1):87-95. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC